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Abstract 
Introduction The objective of this cross-sectional study was to describe the main symptoms associated 
with COVID-19, and their diagnostic characteristics, to aid in the clinical diagnosis. 
Methods An analysis of all patients diagnosed by RT-PCR for SARS-CoV-2 between April and May 
2020 in Argentina was conducted. The data includes clinical and demographic information from all 
subjects at the time of presentation (n=67318, where 12% were positive for SARS-CoV-2). The study 
population was divided into four age groups: pediatric (0-17 years), young adults (18-44 years), adults (45-
64 years), and elderly (65-103 years). Multivariate logistic regression was used to measure the association 
of all symptoms and to create a diagnostic model based on symptoms. 
Results Symptoms associated with COVID-19 were anosmia, dysgeusia, headache, low-grade fever, 
odynophagia, and malaise. However, the presentation of these symptoms was different between the 
different age groups. In turn, at the time of presentation, the symptoms associated with respiratory 
problems (chest pain, abdominal pain, and dyspnea) had a negative association with COVID-19 or did 
not present statistical relevance. On the other hand, the model based on 16 symptoms, age and sex, 
presented a sensitivity of 80% and a specificity of 46%. 
Conclusions There were significant differences between the different age groups. Additionally, there 
were interactions between different symptoms that were highly associated with COVID-19. Finally, our 
findings showed that a regression model based on multiple factors (age, sex, interaction between 
symptoms) can be used as an accessory diagnostic method or a rapid screening of suspected COVID-19 
cases. 
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Introduction 
In December 2019, cases of pneumonia of 
unknown cause were reported in Wuhan, China. 
These cases were epidemiologically associated 
with a wild animal food market.1 A new 
coronavirus was identified as the causative agent 1  
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(2019-nCoV).1-3 In January 2020, China reported 
5900 cases of 2019-nCoV in 33 provinces or 
municipalities.2 In February 2020, the World 
Health Organization (WHO) officially named the 
coronavirus that causes the pandemic as SARS-
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CoV-2, and COVID-19 the disease that this virus 
causes.4 At the beginning of May 2021, the 
number of people infected with SARS-CoV-2 is 
over 155 million worldwide with more than 3 
million deaths.5 The rapid spread of the virus has 
demonstrated its ability to overwhelm the health 
systems of developed countries; this implies a 
greater danger in countries with vulnerable 
health systems.6 These particular characteristics 
underline the importance of adopting social-
distancing measures including quarantines, 
lockdowns and limitations in international travel 
implemented by most governments.  
The identification and isolation of infected 
people through contact tracing or passive 
detection is of vital importance for controlling 
disease spread.7 Currently, SARS-CoV-2 real-time 
polymerase chain reaction (RT-PCR) from 
nasopharyngeal and throat swabs is the diagnostic 
procedure of choice.8 RT-PCR has a sensitivity of 
56% and a specificity of 86%;9 however, the 
collection of quality samples in different stages of 
the infection is a problem that has caused a high 
rate of false negatives.8,10 Additional diagnostic 
approaches include serological tests based on the 
detection of IgM or IgG antibodies. These 
serological tests have a sensitivity range of 77% to 
98% with specificities greater than 91%;11 but 
they have a low sensitivity during the first week of 
infection (30%), therefore being impractical for 
management of early acute cases.12 It should be 
noted that the sensitivity of serological tests 
increases with time, while the sensitivity of RT-
PCR decreases.11 On the other hand, chest CT 
has proven to be a valuable tool in the detection 
of COVID-19 cases. Chest CT has a sensitivity of 
97% with a specificity of 25%.7 Another way to 
detect COVID-19 cases is by identifying the 
symptoms that characterize the clinical 
presentation of the disease. The main clinical 
manifestations of COVID-19 include fever, 
cough, fatigue, headache, myalgia among other 
less frequent symptoms.13-15 However, the 
presentation of symptoms varies among children, 
young adult and the elderly.14,16-18 In addition, 
most of the studies on COVID-19 restrict the 
analysis to confirmed cases,13,15,18,19 which limits 
its capacity to calculate the sensitivity and 
specificity of each sign and symptom.  
The aim of this study was to analyze the 
symptoms included in a large database of 
suspected cases of COVID-19 that were evaluated 
by RT-PCR in Argentina, in order to identify the 
symptoms associated with COVID-19. The 
objectives of this study were: (i) to identify 
symptoms associated with COVID-19 in different 
age groups, (ii) to identify the sensitivity and 
specificity of the main symptoms associated with 
COVID-19 and (iii) to create a model that helps 
to discriminate between cases of COVID-19 and 
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age, sex and RT-PCR results are available 
online.20 The data on symptoms related to these 
individuals was requested to the Ministry of 
Health of the Nation of Argentina for academic 
reasons according to the Access to Public 
Information Law No. 27275.21 In addition, 
according to article 5 of Law 25,326 of 
Argentina,22 the consent or approval of an ethics 
committee was not necessary because the data 
comes from publicly accessible sources. 
Data was obtained from epidemiological files 
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Argentina evaluating suspected cases of COVID-
19. This epidemiological file registers a group of 
23 signs and symptoms identified at presentation. 
This cross-sectional study included 67318 
people evaluated through RT-PCR for SARS-
CoV-2 throughout the country from 1 April 2020 
to 24 May 2020 and included in the registry of 
the National Ministry of Health. The inclusion 
criterion was through the definition of suspected 
cases of COVID-19 by the Ministry of Health 
(eFile 1, supplementary material). Several 
variables including age, sex, RT-PCR result 
(positive or negative), and symptoms at 
presentation were recorded in the 
epidemiological file for each individual. 
Symptoms recorded (presence or absence) 
included anosmia, dysgeusia, arthralgia, 
headache, confusion, seizures, diarrhea, dyspnea 
(defined as the subjective perception of shortness 
of breath by the patient), abdominal pain, chest 
pain, low-grade fever (37.5-37.9°C), high-grade 
fever (≥38°C), respiratory failure (need for 
supplementary oxygen through face mask or 
mechanical ventilation to maintain an adequate 
oxygen supply in blood and tissues), conjunctival 
injection, irritability, malaise, myalgia, food 
refusal, tachypnea (respiratory rate >20/minute 
in adults), use of accessory muscles for breathing 
(UAMB), cough and vomiting. Before 18 May 
2020 the form included “odynophagia” and “sore 
throat”. After 18 May 2020 only odynophagia 
remained in the form. Therefore, to avoid 
eliminating data, these two variables were 
combined as odynophagia. We did not impose 
any further exclusion criteria to limit selection 
bias and all data was included in the analysis. 
This study was carried out according to the 
STROBE statement (eFile 2, supplementary 
material). 
 
Diagnosis by RT-PCR  
The diagnosis by RT-PCR was used as a 
reference standard for the design of the 
regression model. All kits for use in Argentina 
were approved by the local regulatory agency 
(Administración Nacional de Medicamentos, 
Alimentos y Tecnología Médica – ANMAT). A 
sample was taken with a swab from each nostril 
and pharynx. From these samples, an RNA 




Symptoms of COVID-19 have been reported 
to differ in different age groups,16,18,23 therefore, 
four age categories were used for the analysis, 
pediatric (0-17 years), young adult (18-44 years), 
adult (45-64 years) and the elderly (65-103 years). 
The frequencies of comorbidities and 
symptoms were compared between the different 
age groups using Chi-square Pearson test. A p 
value <0.05 was considered significant. 
The association of symptoms (presence versus 
absence) and sex (male versus female) with an RT-
PCR positive result for SARS-CoV-2 was studied 
using multivariate logistic regression analysis 
considering pairwise interactions in each age 
group. The effect of the different covariates was 
quantified by the odds ratio values and a p value 
<0.05 was considered statistically significant. In 
addition, the link between associated symptoms 
and sex in the infected population was analyzed 









where A depends on the set of symptoms, sex, 
and age. This was done on the premise that such 
models should incorporate the fewest significant 
variables and symptoms possible, and that these 
variables be collected without the need for a 
physical exam or laboratory testing (e.g., 
respiratory failure). Symptoms and sex were 
modeled as dichotomous qualitative variables. 
Age was modeled as a continuous quantitative 
variable. In addition, it was evaluated if the age 
squared presented statistical significance. The age 
squared was incorporated because the frequency 
of the population (total and infected) varies as a 
function of age in a parabolic way. 
To develop and test the models, the database 
(n=67318) was randomly divided into two data 
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sets (Training and Testing datasets) with the same 
percentage of RT-PCR positive cases in each one. 
The Training set (n=53854) was used for the 
design and internal validation of the models, 
while the Testing set (n=13464) was used for 
external validation and evaluation of the 
predictive capacity of the model. Models were 
compared using the Akaike Information 
Criterion, the area under the receiver-operator 
characteristic curve (AUC) and the predictive 
value.  
Variables without statistical significance were 
removed by stepwise regression with bidirectional 
elimination based on Akaike information 
criterion (AIC). In addition, we performed a 100-
fold cross-validation method in which the 
training base was partitioned in 100 randomly 
selected subsets and the model was fitted for each 
one. All statistical analyzes were performed with 
R software, packages base, caret, caTools, 
epiDisplays and ggplot2,24-26 and GraphPad Prism 
version 5.00 for Windows (La Jolla California 
USA, www.graphpad.com). R scripts can be seen 





A total of 67318 individuals were included in 
this study; among them, 12% had a positive RT-
PCR for SARS-CoV-2 with a median age of 37 
years-old (IQR: 26-51 years), while the group with 
a negative RT-PCR had a median age of 40 years-
old (IQR: 25-59 years).  
Significant differences were identified in the 
positivity rate of RT-PCR according to the 
interval between the onset of symptoms and the 
time of sampling. It was observed that for the 
day, ranges of 0-3 days, 4-15 days and 16-30 days, 
the proportion of positives was 10.8%, 13.7% 
and 8.6%, respectively. A significant difference 
was observed between the three intervals of days 
(p<0.001). 
Infection rates varied among different age 
groups, with the highest rates being in the 15 to 
60 year-old group (Figure 1). The pediatric group 
(n=10653) presented a rate of 7.9%, and a 
median age of 4 years (IQR 1-10 years); the young 
adult group (n=28909) presented a rate of 15.0%, 
and a median age of 32 years (IQR 26-37 years); 
the adult group (n=14712) presented a rate of 
12.8%, and a median age of 53 years (IQR 48-58 
years); and the elderly group (n=13044) presented 
a rate of 7.0%, and a median age of 77 years 
(IQR 71-85 years).  
Regarding comorbidities, only the frequency 
of asthma and tuberculosis did not show 
statistical differences between age groups (Table 
1). The most frequent comorbidities were 
hypertension, heart failure and diabetes in all 
groups over 18 years of age and asthma in the 
pediatric group. 
The frequency of most symptoms was 
different between the different age groups (Table 
1). Only the frequency of diarrhea, vomiting, 
abdominal pain, conjunctival injection and sex 
did not present differences between the different 
age groups in the infected population. On the 
other hand, the most frequent symptoms in all 
age groups were cough, high fever, odynophagia, 
headache, malaise and myalgia. It should be 
noted that these symptoms not only presented 
the highest frequencies in the infected 
population but also in the total population 
(Table 1). However, the symptoms with the 
highest ratio between the infected population 
and the total population were different between 
age groups. In the pediatric group, the symptoms 
with the highest ratio were anosmia, dysgeusia, 
low fever, headache and myalgia; in the group of 
adults and young adults the highest ratios were 
seen for low fever, headache and cough; in the 
elderly group the symptoms with the highest 
ratios were anosmia dysgeusia, odynophagia, low 
fever and headache. 
Clinical features associated with COVID-19  
The association between sex, symptoms and 
infection with SARS-CoV-2 was studied using 
multivariate logistic regression analysis 
considering pairwise interactions. The odds ratios 
(OR) for each of the symptoms evaluated in the 
four age groups are shown in Figure 2. The 
complete analysis is included in supplementary 
material (eFile 4, supplementary material). Sex 
was significant only for the young adult group, 
with males displaying higher odds than females of 
being infected (OR=1.36, p=0.001).
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Figure 1. Study population and age distribution 
 
a. Frequency of males and females in the total population. b. Frequency of SARS-CoV-2 RT-PCR positive and negative cases in relation to age (years). 
 
Table 1. Frequency of comorbidities and symptoms among the total and infected populations 
 
Total population Infected population 
Ratio between infected 





















































0.220 0.07 0.16 0.13 0.07 

























































<0.001 0.00 0.16 0.13 0.06 
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 Total population Infected population 
Ratio between infected 







































































































































































































0.227 0.15 0.22 0.15 0.08 
























































































































































0.001 0.15 0.26 0.28 0.09 
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<0.001 0.03 0.08 0.05 0.03 
UAMB – use of accessory muscles for breathing; low fever – low grade fever (37.5-37.9°C); high fever – high grade fever (≥38°C). 
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Figure 2. Association between symptoms and COVID-19 in different age groups 
 
a. Symptoms with positive association with COVID-19 in the different age groups (years).  
b. Symptoms with negative (or non-significant) association with COVID-19 in the different age groups 
(years). 
Odds ratio values are reported with their respective 95% confidence interval in those symptoms that 
presented statistical significance (p<0.05). Gray lines in confidence intervals indicate that there is no 
statistical significance, colored lines represent statistical significance.  
UAMB – use of accessory muscles for breathing; low fever – low grade fever (37.5-37.9°C); high fever – 
high grade fever (≥38°C). 
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The main symptoms associated with COVID-
19 among the different groups were anosmia, 
dysgeusia, headache, cough, low fever, malaise 
and odynophagia (Figure 2). However, not all of 
them presented a positive association in the 
different age groups. 
In the pediatric group the symptoms with a 
positive association with COVID-19 were 
anosmia (OR=188.89, p<0.001), dysgeusia 
(OR=4.76, p=0.040), and headache (OR=2.08, 
p=0.007), while chest pain, high fever, food 
refusal, tachypnea, vomiting and respiratory 
failure had a negative association.  
The rest of the symptoms did not show a 
statistically significant association with COVID-
19, but some of them had a significant 
interaction with other symptoms (eFile 4, 
supplementary material). Significantly higher 
ORs were found with the combination of myalgia 
and respiratory failure (OR=2.29, p=0.028), 
seizures and vomiting (OR=7.78, p=0.027), and 
dyspnea and myalgia (OR=28.63, p=0.010). 
In the young adult group, the symptoms with 
a positive association with COVID-19 were 
anosmia (OR=10.36, p<0.001), dysgeusia 
(OR=4.08, p<0.001), low fever (OR=1.72, 
p=0.002) and headache (OR=1.69, p<0.001), 
while abdominal pain, tachypnea, vomiting, 
respiratory failure, UAMB, and odynophagia had 
a negative association (Figure 2). In addition, 
significantly higher ORs were found with the 
combination of mental confusion and tachypnea 
(OR=61.36, p=0.009), and mental confusion and 
odynophagia (OR=50.0, p=0.009). 
In the adult group, the symptoms with a 
positive association with COVID-19 were 
anosmia (OR=9.69, p<0.001), low fever 
(OR=2.50, p<0.001), dysgeusia (OR=2.43, 
p=0.005) and malaise (OR=1.41, p=0.034), while 
mental confusion, conjunctival injection, malaise, 
tachypnea and odynophagia had a negative 
association (Figure 2). In addition, significantly 
higher ORs were found with the combination of 
anosmia and vomiting (OR=133.43, p=0.014), 
and diarrhea and irritability (OR=12.91, 
p=0.032). 
In the elderly group, the symptoms with a 
positive association with COVID-19 were 
odynophagia (OR=1.66, p=0.035), and cough 
(OR=1.62, p=0.010), while arthralgia, mental 
confusion, dyspnea, chest pain, food refusal, 
tachypnea, vomiting, respiratory failure and 
odynophagia had a negative association (Figure 
2). In addition, significantly higher ORs were 
found with the combination of irritability and 
UAMB (OR=6.75, p=0.002), and abdominal pain 
and chest pain (OR=1.52, p=0.001). 
The symptoms associated with COVID-19 
(anosmia, dysgeusia, headache, cough, low fever, 
malaise and odynophagia) presented differences 
in their diagnostic capacity in the different age 
groups (Table 2). In all groups the most specific 
symptoms were anosmia and dysgeusia. However, 
the most sensitive symptoms were cough and 
odynophagia for the pediatric, young adult and 
adult groups; and cough and malaise for the 
elderly group. In addition, some of the symptoms 
associated with COVID-19 presented differences 
according to sex in the different age groups in the 
infected population. In the pediatric group, the 
females presented 1.47 (p=0.017) higher odds 
than the males of presenting headaches. In the 
group of young adults, females had 1.35 
(p=0.002), 1.41 (p<0.001) and 1.35 (p<0.001) 
higher odds of suffering from dysgeusia, 
odynophagia and headache than males. In the 
adult group, females had 1.45 (p=0.021) and 1.27 
(p=0.011) higher odds of suffering from anosmia 
and odynophagia than males; and in the elderly 
group females had 2.63 (p=0.040) higher odds of 
suffering from anosmia than males. 
 
Logistic regression predictive model 
All tested models presented similar 
characteristics regarding area under the curve, 
AIC value and predictive value. The model with 
lower AIC value (35029) presented an 
AUC=0.72. The model considers 16 symptoms 
(1=present, 0=absent), sex (1=male, 0=female), 
and three quantitative variables: age, age squared 
and the number of symptoms (NS). Table 3 
shows the regression coefficient of each variable, 
with its corresponding p-value. Cross validation 
did not show significant differences between the 
model calculated with the training set and 100 
randomly chosen partitions. 
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Table 2. Diagnostic characteristics of the main symptoms associated with COVID-19 
 Pediatric (0-17 years) Young adult (18-44 years) Adult (45-64 years) Elderly (65-103 years) 








































































































































































































































+LR – positive likelihood ratio; -LR – negative likelihood ratio. 
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Table 3. Coefficients of the logistic regression model 
Variable Estimate Std error Odds ratio P value 
Anosmia 2.24000 0.07 173.78 <0.001 
Headache 1.64000 0.15 43.65 <0.001 
Dysgeusia 1.27000 0.08 18.62 <0.001 
Cough 1.07000 0.12 11.75 <0.001 
Low fever 0.99900 0.07 9.98 <0.001 
Dysgeusia :Tachypnea 0.74300 0.22 5.53 <0.001 
Anosmia : Conjunctival injection 0.73600 0.34 5.45 0.030 
Dyspnea : Conjunctival injection 0.67700 0.22 4.75 0.002 
Diarrhea: Chest pain 0.60300 0.18 4.01 <0.001 
Myalgia 0.43800 0.06 2.74 <0.001 
High fever : Tachypnea 0.41900 0.09 2.62 <0.001 
Food refusal 0.26900 0.09 1.86 0.003 
Arthralgia 0.26800 0.07 1.85 <0.001 
High fever 0.24500 0.05 1.76 <0.001 
Malaise 0.23300 0.05 1.71 <0.001 
Dyspnea 0.18100 0.07 1.52 0.008 
Diarrhea 0.14800 0.08 1.41 0.051 
Conjunctival injection 0.08890 0.11 1.23 0.423 
Age 0.03420 0.01 1.08 <0.001 
Age : Sex (M) 0.01810 0.00 1.04 <0.001 
Chest pain 0.01540 0.08 1.04 0.845 
Age : NS 0.01490 0.00 1.03 <0.001 
Age2:Headache 0.00026 0.00 1.00 0.002 
Age2:Cough 0.00015 0.00 1.00 0.009 
Age:Age2 0.00001 0.00 1.00 <0.001 
Age2:NS -0.00012 0.00 1.00 <0.001 
Age2:Sex (M) -0.00020 0.00 1.00 <0.001 
Age2 -0.00113 0.00 1.00 <0.001 
Age:Cough -0.01410 0.01 0.97 0.009 
Age:Headache -0.03390 0.01 0.92 <0.001 
Sex (M) -0.18100 0.10 0.66 0.066 
Tachypnea -0.33600 0.09 0.46 <0.001 
Seizures -0.58700 0.29 0.26 0.041 
NS -0.79500 0.06 0.16 <0.001 
(Intercept) -2.14000 0.12 0.01 <0.001 
Low fever – low grade fever (37.5-37.9°C); high fever – high grade fever (≥38°C); NS – number of 
symptoms. 
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Based on the ROC curve of the model 
(Figure 3), a cut-off line of 0.08839 was chosen to 
obtain a sensitivity of 80% (95% CI: 78-82) and a 
specificity of 46% (95% CI: 45-47). In addition, 
the model presented positive and negative 
predictive values of 17% and 95% respectively, a 
positive likelihood ratio of 1.48 (95% CI: 1.42-
1.54) and a negative likelihood ratio of 0.43 
(95% CI: 0.38-0.49).  
 
Figure 3. ROC curve of the logistic regression 
model based on 16 symptoms (anosmia, 
dysgeusia, low fever, dyspnea, diarrhea, myalgia, 
food refusal, arthralgia, high fever, malaise, 
conjunctival injection, chest pain, cough, 
headache, tachypnea, seizures), sex, age, age 
squared, and number of symptoms. 
 
The variables with the highest coefficients 
were anosmia (estimate coefficient: 2.24), 
headache (estimate coefficient: 1.64), dysgeusia 
(estimate coefficient: 1.27), cough (estimate 
coefficient: 1.07), and low fever (estimate 
coefficient: 0.99). In addition, the interactions 
with the highest coefficients were dysgeusia with 
tachypnea, anosmia with conjunctival injection, 
dyspnea with conjunctival injection and diarrhea 
with chest pain. On the other hand, the variable 
“age squared” captures the way in which the ratio 
rate of positive cases changes with age (Figure 1). 
However, as observed by the value of its 
coefficient (estimate coefficient: -0.00113), its 
contribution is very low. An alternative model 
without the variable age squared is described in 
Supplementary material (eFile 5, supplementary 
material). It can also be observed that the number 
of symptoms (estimate coefficient: -0.00113), had 
a negative contribution in the equation resulting 
in decreases in the likelihood of COVID-19 
infection as the number of symptoms increases. 
 
Discussion 
The analysis of this large cohort allows an 
age-based characterization of the symptoms 
associated with COVID-19 at presentation, in the 
search for an improved clinical based decision 
strategy for the use of diagnostic tests and case 
management. Besides vaccine roll-out, in order to 
slow the spread of SARS-CoV-2, early detection, 
isolation, and the implementation of a robust 
system to trace contacts is required.4 Among the 
non-severe symptomatic cases, non-specific 
symptoms shared with other acute upper-
respiratory infections hamper proper case 
identification and implementation of rapid 
isolation measures. In contrast to most acute 
upper-respiratory infections (including many 
respiratory coronaviruses), COVID-19 poses a 
special challenge in requiring specific 
identification for clinical and public health 
management. To facilitate the early detection of 
patients with COVID-19, we analyzed the 
symptoms of 67318 individuals studied with RT-
PCR, divided into four groups based on age. 
The most frequently reported symptoms 
among case series of COVID-19 include fever, 
cough, dyspnea and shortness of breath.13,27,28 
Other symptoms include sore throat, 
odynophagia, anosmia, dysgeusia, diarrhea, 
nausea, vomiting, myalgia, headache and 
confusion.14,27,29 We found that in the present 
database the most frequent symptoms were 
cough, high fever, odynophagia, headache, 
malaise and myalgia, cough, high-grade fever, and 
odynophagia. The frequency of the symptoms 
showed significant differences between the 
different age groups. However, our analysis 
revealed that the symptoms positively associated 
with COVID-19 in the different groups were 
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some combination of these seven symptoms: 
anosmia, dysgeusia, headache, cough, low fever, 
malaise and odynophagia. In addition, the 
sensitivity and specificity of these seven symptoms 
showed variations between the different age 
groups. Anosmia and dysgeusia were the most 
specific symptoms for COVID-19. However, the 
odds ratio decreased with age, with the pediatric 
group having the highest predictive value 
(anosmia OR=188, dysgeusia OR=4.76, p=0.040), 
the adult group the lowest (anosmia OR=9.69, 
dysgeusia OR=2.43, p<0.005) and no statistical 
significance in the elderly group (anosmia 
OR=1.39 p=0.718, dysgeusia OR=3.59 p=0.184). 
The high value of the OR of anosmia in the 
pediatric group is due to the fact that this 
symptom presented a low frequency (8.2%) in 
this age range, but 66% of the cases with anosmia 
were COVID-19 cases. The decrease in the value 
of the OR of anosmia as age increases, is due to 
the fact that anosmia is more frequent in young 
COVID-19 patients than in elderly patients.14 It 
should be noted that studies carried out in 
Europe reveal frequencies of anosmia and 
dysgeusia greater than 60%,14,29 while in our 
study they presented frequencies lower than 23%. 
Despite the relatively low frequency, these 
symptoms have the highest predictive capacity. 
This is in accordance with other authors stating 
that anosmia and dysgeusia have a positive 
predictive value of 77% each of them and 83% if 
they are together.29 Although anosmia can appear 
in other respiratory infections, it has been 
suggested that the lack of accompanying rhinitis 
or nasal swelling is more typically associated with 
COVID-19;30 we were not able to test this 
hypothesis because the questionnaire does not 
contain rhinitis as a variable. 
Cough was the most frequent and most 
sensitive symptom in each of the four age groups; 
however, a significant association with COVID-
19 was only identified in the elderly group 
(OR=1.62). Similar results were obtained with a 
database from the United States, also using 
multivariate logistic regression. where individuals 
with cough and a median age of 45 years did not 
show significant association with COVID-19.31 
The second most frequent symptom in all age 
groups was high fever. Fever has been reported in 
numerous studies as a frequent symptom of 
COVID-19; however, we found that although 
fever is highly prevalent in many infections, low-
grade fever appears to be specific to COVID-19. 
This could be observed in the group of young 
adults and adults who presented significant odds 
ratios for low-grade fever (37.5-37.9°C) 
(OR=1.72, OR=2.5). While high fever (≥38°C) 
presented a negative association with individuals 
positive for SARS-CoV-2 in the pediatric group, 
and had no statistical significance in the other 
groups.  
Another group of symptoms, including 
respiratory symptoms, showed a negative (or non-
significant) association with a positive RT-PCR 
for SARS-CoV-2, therefore suggesting alternative 
diagnoses (Figure 2b). This is in line with the 
findings of a study from United Kingdom and 
United States,31 where anosmia presented the 
highest OR, while respiratory symptoms (chest 
pain, abdominal pain and dyspnea) presented the 
lowest values or lacked statistical significance. 
Our analysis also revealed that some 
symptoms interact with each other, modifying 
their ORs. It should be noted that29,30 
combinations of nonspecific symptoms resulted 
in high ORs such as dyspnea and myalgia 
(OR=28.63) in the pediatric group, mental 
confusion and tachypnea (OR=61.36) in the 
young adult group, diarrhea and irritability 
(OR=12.91) in the adult group and irritability 
and UAMB (OR=6.75) in the elderly group. This 
highlights that many symptoms are not 
independent, and that certain combinations may 
be more specific of COVID-19. 
Middle-aged men appear to be more likely to 
be infected with COVID-19 than women. This 
could be observed in our study in the group of 
young adults (OR=1.36) and has been reported in 
studies with a median age of 50 years.32 In 
addition, the presentation of symptoms was 
different between males and females, where 
females showed a higher prevalence of anosmia, 
dysgeusia, headache, and odynophagia in other 
studies.14 This was also observed in our study, 
where females had higher odds of presenting 
these symptoms than males in the different age 
groups. 
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The diagnosis of COVID-19 is complex, 
since multiple factors such as age, sex and the 
interaction between different symptoms have to 
be taken into account. Therefore, we also 
developed a model based on symptoms at 
presentation, sex and age. Our model presents 
better diagnostic characteristics than individual 
symptoms, with an AUC=0.72, a sensitivity of 
80% and a specificity of 46%. The main variables 
of this model were anosmia, headache, dysgeusia 
cough and low fever among other symptoms and 
symptom interactions (Table 3). Age, age squared, 
and sex had lower coefficients in the model. 
Although the age-dependent variability in the 
proportion of RT-PCR positive results in our 
study population might reflect differences in 
exposure due to school closure and an active 
protection of the elderly, the model achieves 
comparable predictive values in all age groups. 
Furthermore, our model achieved similar 
diagnostic characteristics with another symptom-
based regression model.31 That model, which 
evaluated data from the United States and the 
United Kingdom presented an AUC=0.76;31 
therefore, considering our results and those of 
studies carried out in those countries,31 the 
regression models based on symptoms achieve an 
AUC greater than 0.70. However, in view of the 
burden of morbidity and mortality in high-risk 
groups, models to predict the likelihood of 
infection should be interpreted with caution and 
not be used to limit the corresponding testing of 
groups at increased risk of severe disease.  
This study was conducted with patients 
diagnosed between April and May 2020, prior to 
the influenza season in Argentina; this should 
also place our results in the adequate context of 
the alternative diagnoses that could modify the 
specificity of the symptoms based on the type and 
prevalence of these agents; in the current case, 
with most cases occurring in Buenos Aires and its 
metropolitan area, which was affected by its 
largest recorded dengue outbreak and a 
significant reduction of influenza-like illnesses 
(probably related to the lockdown measures) 
during that period.33 
This study has limitations; first the reference 
diagnostic technique used in this study was RT-
PCR which has a sensitivity of 56-83%.9 
Therefore, the sensitivity and specificity measures 
of the model are affected by that diagnostic 
accuracy. While suffering from the lack of a 
highly sensitive diagnostic standard, identifying 
clinical characteristics that raise the pretest 
probability of the infection could help 
interpretations of the RT-PCR result when 
combined with predictive models, 
epidemiological factors and complementary 
diagnostic methods like chest imaging.34 Second, 
in our analysis, a significantly higher probability 
of a positive RT-PCR was identified if the test was 
performed when the interval between symptoms 
initiation and sampling was between 4 and 15 
days. Third, another limitation derives from the 
circumstance of the data collection, which has 
not been designed as a prospective research tool 
but rather as a surveillance system with no 
monitoring system and therefore subject to errors 
in data capture. Finally, all symptoms were 
recorded by the physicians at initial presentation, 




In summary, this symptoms-based analysis of 
a cohort of suspected COVID-19 cases identified 
a group of symptoms (anosmia, dysgeusia, 
headache, cough, low-grade fever, malaise and 
odynophagia) with significant association with a 
positive RT-PCR in different age groups. The 
presentation of symptoms showed significant 
differences between the different age groups. In 
those younger than 65 years, anosmia and 
dysgeusia were the symptoms most frequently 
associated with COVID-19, while in the elderly 
(65-103 years), cough and odynophagia were the 
symptoms most frequently associated. In 
addition, low-grade fever instead of high-grade 
fever was associated with COVID-19 in the young 
adult and adult age groups (18-64 years); there 
were also interactions between different 
symptoms, which means that there were certain 
combinations, which although appearing at low 
frequency, were highly associated to COVID-19. 
Finally, our findings show that a regression 
model based on multiple factors (age, sex, 
interaction between symptoms) can be used as an 
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accessory diagnostic method or for the rapid 
screening of suspected COVID-19 cases. 
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